Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAME (N-4-Tosyl-L-arginine methyl ester) 是后期促进复合体(APC/C 或 APC)的抑制剂,可与 APC/C 结合并阻止其通过 Cdc20 和 Cdh1 活化,产生有丝分裂阻滞。 在相同实验条件下,摩尔浓度相同的化合物盐形式与游离态具有相同的生物活性,但盐形式 TAME hydrochloride 的水溶性和稳定性通常比游离态更好。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 177 | 5日内发货 | ||
5 mg | ¥ 268 | 5日内发货 | ||
10 mg | ¥ 428 | 5日内发货 | ||
25 mg | ¥ 746 | 5日内发货 | ||
1 mL * 10 mM (in DMSO) | ¥ 473 | 5日内发货 |
TAME 的其他形式现货产品:
产品描述 | Tosyl-L-Arginine Methyl Ester (TAME (N-4-Tosyl-L-arginine methyl ester)) is an APC inhibitor. |
靶点活性 | APC:12 µM. |
体外活性 | TAME inhibits cyclin proteolysis in mitotic Xenopus egg extract with IC50 of 12 μM. TAME at concentration of 1-200 μM arrests interphase extract treated with recombinant cyclin B1/Cdc2 complex in mitosis, with stable cyclin B1 and phosphorylated Cdc27. TAME at concentration of 200 μM dramaticly inhibits the ubiquitin ligase activity of the Anaphase-Promoting Complex (APC), accompanied by reduced binding of Cdh1 to APC. TAME addition to interphase extract reduces Cdc20 association with the APC in a dose-dependent manner partly by binding directly to APC, and the contribution motif is the C-terminal isoleucine-arginine (IR) tail on APC. [1] TAME is hydrolysed by trypsin with Km of 0.328 mM. [2] TAME accelerates the ATP hydrolysis process about 12-fold. [3] TAME interacts with β and γ phosphate and the adenine ring of ATP by the guanidinium group and the aromatic ring. [4] TAME at concentration of 50 mM inhibits nutrient-induced germination and pressure-induced germination at 600 MPa in Bacillus subtilis. [5] TAME induces a concentration dependent contractile response on ileal strips with EC50 of 4.3 x 103 M. [6] |
别名 | N-[(4-甲基苯基)磺酰基]-L-精氨酸甲酯, Tosylarginine methyl ester, N-4-Tosyl-L-arginine methyl ester |
分子量 | 342.41 |
分子式 | C14H22N4O4S |
CAS No. | 901-47-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 63 mg/mL (184 mM)
Ethanol: 3 mg/mL (8.76 mM)
DMSO: 64 mg/mL (186.9 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / Ethanol / DMSO | 1 mM | 2.9205 mL | 14.6024 mL | 29.2048 mL | 73.0119 mL |
5 mM | 0.5841 mL | 2.9205 mL | 5.841 mL | 14.6024 mL | |
H2O / DMSO | 10 mM | 0.292 mL | 1.4602 mL | 2.9205 mL | 7.3012 mL |
20 mM | 0.146 mL | 0.7301 mL | 1.4602 mL | 3.6506 mL | |
50 mM | 0.0584 mL | 0.292 mL | 0.5841 mL | 1.4602 mL | |
100 mM | 0.0292 mL | 0.146 mL | 0.292 mL | 0.7301 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TAME 901-47-3 Cell Cycle/Checkpoint APC Inhibitor N-[(4-甲基苯基)磺酰基]-L-精氨酸甲酯 Anaphase promoting complex Tosylarginine methyl ester N-4-Tosyl-L-arginine methyl ester inhibit inhibitor